Target intelligence / Profile preview

Fusobacterium nucleatum outer membrane receptors (Fn OMRs)

Target
Fn OMRs
Molecular classification
Receptor, Other
01

Overview

Fusobacterium nucleatum outer membrane receptors (OMRs) are a group of surface-exposed proteins, primarily adhesins and porins, that mediate the interaction between the Gram-negative bacterium F. nucleatum and host cells. Key members include FadA, which binds to host E-cadherin to activate oncogenic Wnt/beta-catenin signaling, and Fap2, which binds to Gal-GalNAc on tumor cells and the inhibitory receptor TIGIT on immune cells to facilitate colonization and immune evasion. These proteins are critical for the bacterium's role as an opportunistic pathogen in colorectal cancer (CRC), where they promote tumor progression, inflammation, and chemoresistance. Additionally, OMRs like RadD and FomA are involved in interspecies co-aggregation and biofilm formation in periodontal diseases. Therapeutic strategies targeting these receptors include small molecule inhibitors, monoclonal antibodies, and vaccines designed to disrupt bacterial adhesion or neutralize their immunosuppressive effects.

Other names
Fusobacterium nucleatum outer membrane proteinsFn OMPsFusobacterium adhesinsFusobacterium adhesin A (FadA)Fusobacterium adhesin protein 2 (Fap2)Arginine-specific adhesin (RadD)Fusobacterium outer membrane protein A (FomA)CmpA
02

Mechanism of action

Inhibition of bacterial adhesion and invasion, blockade of oncogenic signaling pathways (e.g., Wnt/beta-catenin), and neutralization of immune checkpoint interactions (e.g., Fap2-TIGIT) to restore anti-tumor immunity and reduce bacterial colonization.

03

Biological functions

AdhesionInvasionImmune responseCell proliferationCell deathBiofilm formation
04

Disease associations

CancerInflammationInfectionOther
05

Safety considerations

Gut dysbiosis due to non-selective bacterial depletionDevelopment of antimicrobial resistancePotential for systemic inflammatory responses upon bacterial lysisOff-target effects on beneficial commensal microbiota
06

Interacting drugs

Metronidazole

5 more in the full profile.

07

Biomarkers

Fusobacterium nucleatum DNA (fecal or tumor-associated)FadA gene expression levelsFap2 protein levelsGal-GalNAc expression in tumor tissueTIGIT expression on tumor-infiltrating lymphocytes

Beyond the preview

Go deeper on Fusobacterium nucleatum outer membrane receptors (Fn OMRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fusobacterium nucleatum outer membrane receptors (Fn OMRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call